IFLR is part of Legal Benchmarking Limited, 1-2 Paris Garden, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement


7,267 results7,267 results
326
of
364
Deal Highlights
0 results0 results
Deal Name Deal Date Firm Name Jurisdiction Deal Type Lawyer Names Client Names Client Role
There are no results
By Firm
0 results0 results
Firm Name Jurisdiction Total Deals Deals (Last 12 Months)
There are no results
Among top moves, Freshfields and Baker McKenzie strengthened their corporate benches, while Sidley added a former Ashurst partner in Hong Kong
Additions at King & Spalding, Latham, White & Case and Norton Rose Fulbright spanned fund finance, capital markets, M&A, energy and data centres, while Orrick added a Willkie partner to lead French project finance
Additions from Clifford Chance, Mayer Brown, Akin and Freshfields headlined a week that also included an M&A hire for Paul Weiss and Cleary’s hire of a PE-focused debt finance partner
M&A
Clemens York discusses how expanding EU regulatory regimes are reshaping transaction execution, from data preparation and deal documentation to cross-practice matter staffing
As AI changes what sponsors buy, advisers must sharpen their focus on valuation, data rights and resilience
Paul Hastings’ latest finance hires from Cahill and Ropes & Gray stood out in a week that also saw Akin and Charles Russell Speechlys add corporate partners
M&A
The firm believes its sector focus will help it stand out in a competitive market for M&A advisers, its global managing partner tells IFLR
We round up this week’s top moves in the finance, corporate, M&A and PE practices in the UK, France, the US and Germany
Sponsored

Sponsored

  • IFLR1000
    Sponsored by Bär & Karrer
    Nxera Pharma Co. Ltd, listed on the Tokio Stock Exchange, has entered into an exclusive licensing agreement with Santhera Pharmaceuticals under which Nxera will commercialize the drug AGAMREE® in Japan, South Korea, Australia and New Zealand. Concurrently, Nxera invests in SIX-listed Santhera Pharmaceuticals Holding AG.
  • IFLR1000
    Sponsored by Bär & Karrer
    In connection with a carve-out process, the Ortlinghaus Group sold its EM+H Division, which encompasses among others the production and sale of electromagnetic brakes and clutches as well as pneumatic toothed clutches and other trade goods to Stüwe Switzerland AG, a group company of Stüwe GmbH & Co. KG.
  • IFLR1000
    Sponsored by Zepos & Yannopoulos
    Zepos & Yannopoulos continues its longstanding presence and active involvement in landmark transactions in the food & beverage retail sector in Greece. We advised ANEDIK Kritikos on the sale of 100% of ANEDIK Kritikos S.A. to Diamantis Masoutis S.A., paving the way for the creation of a new national retail group, subject to approval by the Hellenic Competition Commission.